Cargando…
The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC)
Tuberous sclerosis complex (TSC) is a model disorder for understanding brain development because the genes that cause TSC are known, many downstream molecular pathways have been identified, and the resulting perturbations of cellular events are established. TSC, therefore, provides an intellectual f...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381175/ https://www.ncbi.nlm.nih.gov/pubmed/32765227 http://dx.doi.org/10.3389/fnana.2020.00039 |
_version_ | 1783562993055825920 |
---|---|
author | Feliciano, David M. |
author_facet | Feliciano, David M. |
author_sort | Feliciano, David M. |
collection | PubMed |
description | Tuberous sclerosis complex (TSC) is a model disorder for understanding brain development because the genes that cause TSC are known, many downstream molecular pathways have been identified, and the resulting perturbations of cellular events are established. TSC, therefore, provides an intellectual framework to understand the molecular and biochemical pathways that orchestrate normal brain development. The TSC1 and TSC2 genes encode Hamartin and Tuberin which form a GTPase activating protein (GAP) complex. Inactivating mutations in TSC genes (TSC1/TSC2) cause sustained Ras homologue enriched in brain (RHEB) activation of the mammalian isoform of the target of rapamycin complex 1 (mTORC1). TOR is a protein kinase that regulates cell size in many organisms throughout nature. mTORC1 inhibits catabolic processes including autophagy and activates anabolic processes including mRNA translation. mTORC1 regulation is achieved through two main upstream mechanisms. The first mechanism is regulation by growth factor signaling. The second mechanism is regulation by amino acids. Gene mutations that cause too much or too little mTORC1 activity lead to a spectrum of neuroanatomical changes ranging from altered brain size (micro and macrocephaly) to cortical malformations to Type I neoplasias. Because somatic mutations often underlie these changes, the timing, and location of mutation results in focal brain malformations. These mutations, therefore, provide gain-of-function and loss-of-function changes that are a powerful tool to assess the events that have gone awry during development and to determine their functional physiological consequences. Knowledge about the TSC-mTORC1 pathway has allowed scientists to predict which upstream and downstream mutations should cause commensurate neuroanatomical changes. Indeed, many of these predictions have now been clinically validated. A description of clinical imaging and histochemical findings is provided in relation to laboratory models of TSC that will allow the reader to appreciate how human pathology can provide an understanding of the fundamental mechanisms of development. |
format | Online Article Text |
id | pubmed-7381175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73811752020-08-05 The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC) Feliciano, David M. Front Neuroanat Neuroscience Tuberous sclerosis complex (TSC) is a model disorder for understanding brain development because the genes that cause TSC are known, many downstream molecular pathways have been identified, and the resulting perturbations of cellular events are established. TSC, therefore, provides an intellectual framework to understand the molecular and biochemical pathways that orchestrate normal brain development. The TSC1 and TSC2 genes encode Hamartin and Tuberin which form a GTPase activating protein (GAP) complex. Inactivating mutations in TSC genes (TSC1/TSC2) cause sustained Ras homologue enriched in brain (RHEB) activation of the mammalian isoform of the target of rapamycin complex 1 (mTORC1). TOR is a protein kinase that regulates cell size in many organisms throughout nature. mTORC1 inhibits catabolic processes including autophagy and activates anabolic processes including mRNA translation. mTORC1 regulation is achieved through two main upstream mechanisms. The first mechanism is regulation by growth factor signaling. The second mechanism is regulation by amino acids. Gene mutations that cause too much or too little mTORC1 activity lead to a spectrum of neuroanatomical changes ranging from altered brain size (micro and macrocephaly) to cortical malformations to Type I neoplasias. Because somatic mutations often underlie these changes, the timing, and location of mutation results in focal brain malformations. These mutations, therefore, provide gain-of-function and loss-of-function changes that are a powerful tool to assess the events that have gone awry during development and to determine their functional physiological consequences. Knowledge about the TSC-mTORC1 pathway has allowed scientists to predict which upstream and downstream mutations should cause commensurate neuroanatomical changes. Indeed, many of these predictions have now been clinically validated. A description of clinical imaging and histochemical findings is provided in relation to laboratory models of TSC that will allow the reader to appreciate how human pathology can provide an understanding of the fundamental mechanisms of development. Frontiers Media S.A. 2020-07-14 /pmc/articles/PMC7381175/ /pubmed/32765227 http://dx.doi.org/10.3389/fnana.2020.00039 Text en Copyright © 2020 Feliciano. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Feliciano, David M. The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC) |
title | The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC) |
title_full | The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC) |
title_fullStr | The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC) |
title_full_unstemmed | The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC) |
title_short | The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC) |
title_sort | neurodevelopmental pathogenesis of tuberous sclerosis complex (tsc) |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381175/ https://www.ncbi.nlm.nih.gov/pubmed/32765227 http://dx.doi.org/10.3389/fnana.2020.00039 |
work_keys_str_mv | AT felicianodavidm theneurodevelopmentalpathogenesisoftuberoussclerosiscomplextsc AT felicianodavidm neurodevelopmentalpathogenesisoftuberoussclerosiscomplextsc |